Synthesis, Inhibition Potency, Binding Mode, and Antiprotozoal Activities of Fluorescent Inhibitors of Trypanothione Reductase Based on Mepacrine‐Conjugated Diaryl Sulfide Scaffolds
暂无分享,去创建一个
F. Diederich | R. Krauth-Siegel | R. Brun | M. Kaiser | Bernhard Stump | Christian Eberle | Johannes A. Burkhard
[1] Isabelle R. E. Nett,et al. Improved Tricyclic Inhibitors of Trypanothione Reductase by Screening and Chemical Synthesis , 2009, ChemMedChem.
[2] I. Gilbert,et al. Synthesis and Evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) Analogues as Inhibitors of Trypanothione Reductase , 2009, ChemMedChem.
[3] F. Diederich,et al. Diaryl sulfide-based inhibitors of trypanothione reductase: inhibition potency, revised binding mode and antiprotozoal activities. , 2008, Organic & biomolecular chemistry.
[4] F. Diederich,et al. Betraying the Parasite’s Redox System: Diaryl Sulfide‐Based Inhibitors of Trypanothione Reductase: Subversive Substrates and Antitrypanosomal Properties , 2007, ChemMedChem.
[5] I. Gilbert,et al. Target assessment for antiparasitic drug discovery. , 2007, Trends in parasitology.
[6] W. Hunter. Picking pockets to fuel antimicrobial drug discovery. , 2007, Biochemical Society transactions.
[7] O. Tapia,et al. Interaction energies of nitrofurans with trypanothione reductase and glutathione reductase studied by molecular docking , 2007 .
[8] J. Alvar,et al. Leishmaniasis and poverty. , 2006, Trends in parasitology.
[9] D. Boykin,et al. Accumulation and Intracellular Distribution of Antitrypanosomal Diamidine Compounds DB75 and DB820 in African Trypanosomes , 2006, Antimicrobial Agents and Chemotherapy.
[10] V. Yardley,et al. Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide. , 2005, Journal of medicinal chemistry.
[11] R. L. Krauth-Siegel,et al. Dithiolproteine als Hüter des intrazellulären Redoxmilieus bei Parasiten: alte und neue Wirkstoff‐Targets bei Trypanosomiasis und Malaria , 2005 .
[12] R. Schirmer,et al. Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. , 2005, Angewandte Chemie.
[13] R. Krauth-Siegel,et al. Parasite-specific trypanothione reductase as a drug target molecule , 2003, Parasitology Research.
[14] Wim G J Hol,et al. Drugs to Combat Tropical Protozoan Parasites , 2002, Science.
[15] H. D. Koning. Transporters in African trypanosomes: role in drug action and resistance. , 2001 .
[16] J. Keiser,et al. New drugs for the treatment of human African trypanosomiasis: research and development. , 2001, Trends in parasitology.
[17] D. Marks,et al. Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines , 2000 .
[18] T. Nevalainen,et al. Synthesis and in vitro evaluation of novel morpholinyl- and methylpiperazinylacyloxyalkyl prodrugs of 2-(6-methoxy-2-naphthyl)propionic acid (Naproxen) for topical drug delivery. , 2000, Journal of medicinal chemistry.
[19] H. Tanowitz,et al. African trypanosomiasis (sleeping sickness). , 2000 .
[20] R. Krauth-Siegel,et al. Inhibition of Trypanosoma cruzi trypanothione reductase by acridines: kinetic studies and structure-activity relationships. , 1999, Journal of medicinal chemistry.
[21] A. Orjales,et al. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives. , 1999, Journal of medicinal chemistry.
[22] M. Berriman,et al. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors. , 1999, Structure.
[23] Ken Blanchard,et al. Mission Possible , 1999 .
[24] A. Fairlamb,et al. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. , 1998, Journal of medicinal chemistry.
[25] E. Davioud‐Charvet,et al. New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase. , 1997, Bioorganic & medicinal chemistry.
[26] C. Sergheraert,et al. 2-Amino diphenylsulfides as inhibitors of trypanothione reductase: modification of the side chain. , 1996, Bioorganic & medicinal chemistry.
[27] W. Kabsch,et al. Crystal structure of the Trypanosoma cruzi trypanothione reductase·mepacrine complex , 1996, Proteins.
[28] C. Sergheraert,et al. 2-Amino diphenylsulfides as new inhibitors of trypanothione reductase. , 1995, International journal of antimicrobial agents.
[29] A. Fairlamb,et al. Uptake of Diamidine Drugs by the P2 Nucleoside Transporter in Melarsen-sensitive and -resistant Trypanosoma brucei brucei(*) , 1995, The Journal of Biological Chemistry.
[30] Paul R. Gerber,et al. MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..
[31] J. Blanchard,et al. Mechanism of reduction of quinones by Trypanosoma congolense trypanothione reductase. , 1994, Biochemistry.
[32] A. Fairlamb,et al. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. , 1992, The Biochemical journal.
[33] A. Fairlamb,et al. "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[34] B. Chait,et al. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. , 1985, Science.
[35] J. Wilshire,et al. The preparation of some 2-nitroacridines and related compounds , 1981 .